𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CYP2C19 genotype–guided antiplatelet therapy in ST-segment elevation myocardial infarction patients—Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study

✍ Scribed by Bergmeijer, Thomas O.; Janssen, Paul W.A.; Schipper, Jurjan C.; Qaderdan, Khalid; Ishak, Maycel; Ruitenbeek, Rianne S.; Asselbergs, Folkert W.; van ‘t Hof, Arnoud W.J.; Dewilde, Willem J.M.; Spanó, Fabrizio; Herrman, Jean-Paul R.; Kelder, Johannes C.; Postma, Maarten J.; de Boer, Anthonius; Deneer, Vera H.M.; ten Berg, Jurriën M.

Book ID
122216073
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
490 KB
Volume
168
Category
Article
ISSN
1097-6744

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcome Comparison of 600- and 300-mg Lo
Outcome Comparison of 600- and 300-mg Loading Doses of Clopidogrel in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: Results From the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Randomized Study
✍ Giuseppe Patti; György Bárczi; Dejan Orlic; Fabio Mangiacapra; Giuseppe Colonna; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 781 KB
Rationale and design of the EMBRACE STEM
Rationale and design of the EMBRACE STEMI Study: A phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction
✍ Chakrabarti, Anjan K.; Feeney, Kristin; Abueg, Cassandra; Brown, David A.; Czyz, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 322 KB